NUVATION BIO INC (NUVB) Stock Earnings Estimates
NYSE:NUVB • US67080N1019
5.77 USD
-0.02 (-0.35%)
At close: Feb 13, 2026
5.86 USD
+0.09 (+1.56%)
After Hours: 2/13/2026, 8:04:00 PM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.873M | 58.018M 636.92% | 168.92M 191.15% | 329.06M 94.80% | 491.25M 49.29% | 704.39M 43.39% | 897.21M 27.37% | 1.157B 28.96% | 1.413B 22.13% | 1.633B 15.57% | |||
| EBITDA YoY % growth | -112.13M -20.39% | -99.6M 11.17% | -166.874M -67.54% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -112.33M -20.37% | -99.822M 11.14% | -167.557M -67.86% | -220.711M -31.72% | -154.348M 30.07% | -65.079M 57.84% | 42.32M 165.03% | 107.45M 153.90% | 291.83M 171.60% | 528.29M 81.03% | 785.68M 48.72% | 1.006B 28.04% | |
| Operating Margin | N/A | N/A | -2,128.25% | -380.42% | -91.37% | -19.78% | 8.61% | 15.25% | 32.53% | 45.66% | 55.60% | 61.60% | |
| EPS YoY % growth | -0.48 -9.09% | -0.34 29.17% | -0.52 -52.94% | -0.60 -14.75% | -0.50 16.80% | -0.18 63.67% | 0.85 569.38% | 3.43 304.82% | -0.23 -106.85% | 0.17 173.91% | 0.59 241.18% | N/A |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.09 39.24% | -0.21 -33.88% | -0.17 2.00% | -0.12 26.58% | -0.08 10.66% | -0.05 77.62% | -0.05 68.77% | -0.12 1.02% | 0.13 259.09% | 0.11 319.15% | 0.10 300.00% | 0.11 190.35% |
| Revenue Q2Q % growth | 38.615M 576.15% | 30.655M 894.00% | 38.699M 700.72% | 47.129M 259.21% | 56.938M 47.45% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -32.056M 40.57% | -46.644M 20.95% | -43.559M 31.50% | -40.687M 27.90% | -39.913M -24.51% | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.16 -6.67% | -0.17 | 0.01 | 6.98% |
| Q2 2025 Q2Q % growth | -0.17 -13.33% | -0.17 | 0.00 | 0.88% |
| Q1 2025 Q2Q % growth | -0.16 -128.57% | -0.16 | 0.00 | 0.90% |
| Q4 2024 Q2Q % growth | -0.15 -150.00% | -0.14 | -0.01 | -6.56% |
| Q3 2024 Q2Q % growth | -0.15 -66.67% | -0.13 | -0.02 | -13.12% |
| Q2 2024 Q2Q % growth | -0.15 -66.67% | -0.06 | -0.09 | -151.38% |
| Q1 2024 Q2Q % growth | -0.07 30.00% | -0.10 | 0.03 | 28.36% |
| Q4 2023 Q2Q % growth | -0.06 40.00% | -0.11 | 0.05 | 43.89% |
| Q3 2023 Q2Q % growth | -0.09 25.00% | -0.11 | 0.02 | 19.54% |
| Q2 2023 Q2Q % growth | -0.09 43.75% | -0.11 | 0.02 | 21.10% |
| Q1 2023 Q2Q % growth | -0.10 | -0.10 | 0.00 | 1.96% |
| Q4 2022 Q2Q % growth | -0.10 16.67% | -0.12 | 0.02 | 14.75% |
| Q3 2022 Q2Q % growth | -0.12 -9.09% | -0.14 | 0.02 | 15.97% |
| Q2 2022 Q2Q % growth | -0.16 -77.78% | -0.14 | -0.02 | -18.07% |
| Q1 2022 Q2Q % growth | -0.10 16.67% | -0.15 | 0.05 | 31.92% |
| Q4 2021 Q2Q % growth | -0.12 -152.08% | -0.12 | 0.00 | 0.58% |
| Q3 2021 Q2Q % growth | -0.11 | -0.11 | 0.00 | -1.74% |
| Q2 2021 Q2Q % growth | -0.09 | -0.10 | 0.01 | 9.96% |
| Q1 2021 Q2Q % growth | -0.12 | -0.07 | -0.05 | -68.07% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 13.12M 1,704.68% | 6.746M | 6.374M | 94.49% |
| Q2 2025 Q2Q % growth | 4.833M 236.79% | 364.283K | 4.469M | 1,226.72% |
| Q1 2025 Q2Q % growth | 3.084M | 425.003K | 2.659M | 625.64% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 6.67% | 4.7% | 1.31% | 10.47% |
| Revenue | 7.25% | 18.39% | 3.86% | 92.32% |